{"data":[{"accessionNo":"0001104659-26-100403","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":"87990A106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":11581565,"percentOfClass":5.2,"filedAt":"2026-08-24","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001104659-26-100403","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":"87990A106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":11579445,"percentOfClass":5.2,"filedAt":"2026-08-24","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001104659-26-100403","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":"87990A106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":11581565,"percentOfClass":5.2,"filedAt":"2026-08-24","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001104659-26-100403","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":"87990A106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":11581565,"percentOfClass":5.2,"filedAt":"2026-08-24","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-076892","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-25","reportingPerson":"Peter Svennilson","reportingCik":"0001606074","personType":"IN","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-076892","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-25","reportingPerson":"The Column Group Opportunity III GP, LP","reportingCik":"0001932874","personType":"PN","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-076892","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-25","reportingPerson":"TCG Opportunity III GP, LLC","reportingCik":"0001932445","personType":"OO","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-076892","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-25","reportingPerson":"Tim Kutzkey","reportingCik":"0001614186","personType":"IN","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-076892","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-25","reportingPerson":"The Column Group Opportunity III, LP","reportingCik":"0001931825","personType":"PN","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-076892","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-25","reportingPerson":"The Column Group III-A, LP","reportingCik":"0001668085","personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-076892","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-25","reportingPerson":"The Column Group III GP, LP","reportingCik":"0001790965","personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-076892","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-25","reportingPerson":"The Column Group III, LP","reportingCik":"0001668159","personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-26","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-049218","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-10","reportingPerson":"Tim Kutzkey","reportingCik":"0001614186","personType":"IN","sharesOwned":54313559,"percentOfClass":25.4,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-049218","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-10","reportingPerson":"Peter Svennilson","reportingCik":"0001606074","personType":"IN","sharesOwned":54313559,"percentOfClass":25.4,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-049218","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-10","reportingPerson":"The Column Group Opportunity III, LP","reportingCik":"0001931825","personType":"PN","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-049218","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-10","reportingPerson":"The Column Group Opportunity III GP, LP","reportingCik":"0001932874","personType":"PN","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-049218","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-10","reportingPerson":"TCG Opportunity III GP, LLC","reportingCik":"0001932445","personType":"OO","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-049218","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-10","reportingPerson":"The Column Group III GP, LP","reportingCik":"0001790965","personType":"PN","sharesOwned":5000000,"percentOfClass":2.3,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-049218","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-10","reportingPerson":"The Column Group III-A, LP","reportingCik":"0001668085","personType":"PN","sharesOwned":2651817,"percentOfClass":1.2,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-26-049218","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-10","reportingPerson":"The Column Group III, LP","reportingCik":"0001668159","personType":"PN","sharesOwned":2348183,"percentOfClass":1.1,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-25-322770","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-15","reportingPerson":"The Column Group Opportunity III, LP","reportingCik":"0001931825","personType":"PN","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2025-12-17","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-25-322770","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-15","reportingPerson":"TCG Opportunity III GP, LLC","reportingCik":"0001932445","personType":"OO","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2025-12-17","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-25-322770","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-15","reportingPerson":"The Column Group Opportunity III GP, LP","reportingCik":"0001932874","personType":"PN","sharesOwned":49313559,"percentOfClass":23.1,"filedAt":"2025-12-17","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-25-322770","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-15","reportingPerson":"The Column Group III GP, LP","reportingCik":"0001790965","personType":"PN","sharesOwned":9400290,"percentOfClass":4.4,"filedAt":"2025-12-17","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-25-322770","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-15","reportingPerson":"The Column Group III-A, LP","reportingCik":"0001668085","personType":"PN","sharesOwned":4985570,"percentOfClass":2.3,"filedAt":"2025-12-17","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"},{"accessionNo":"0001193125-25-322770","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001858848","issuerName":"Tenaya Therapeutics, Inc.","ticker":"TNYA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-15","reportingPerson":"The Column Group III, LP","reportingCik":"0001668159","personType":"PN","sharesOwned":4414720,"percentOfClass":2.1,"filedAt":"2025-12-17","canonicalUrl":"https://xoomar.com/markets/stocks/tnya"}],"updatedAt":"2026-11-03T21:46:15.478Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/tnya","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}